One of the growing demands regulators and consumers are pushing on distributors is the demand for sustainable business practices. There are a variety of reasons for this, such as growing concern about the industry’s environmental impact...
Toward the beginning of the new year, we like to take a look at some of the biggest trends that will affect the pharmaceutical industry in the coming months. This year, trending developments range from AI...
In the healthcare supply chain world, the year 2020 created a notable split. Even those not directly involved in the healthcare industry, that would otherwise have no vested interest in healthcare-specific supply chain knowledge, felt the...
The 2020 COVID-19 pandemic has made a permanent mark on the healthcare industry. Many changes have taken place, new regulations and requirements are set for future implementation, and patients are now expecting a new standard of...
The United States Food and Drug Administration (FDA) estimates that more than 30 million people living in the U.S. are affected by over 7,000 rare diseases. Many of these rare diseases do not...
Your success as a pharmaceutical company heavily relies on the implementation of a quality management system. With ever-changing FDA regulations and technological advancements, the demand for solid infrastructure with quality in mind is increasing. Truthfully, the...
The U.S. Food and Drug Administration (FDA) recently announced the proposed rule, which aims to create a uniform national licensing standard for wholesale distributors and third-party logistics providers (3PLs). Historically, states have set...
There are a variety of challenges that patients may face when accessing medication. In fact, a 2019 study on medication access identified 17 distinct barriers that patients must overcome, including costs, transportation, and...
With all the challenges facing the global supply chain in recent years, including materials and labor shortages, it comes as no surprise that third-party logistics (3PL) providers are looking to utilize cutting edge technologies to create...
Over the past 5 years, the FDA has approved an average of 51 novel drugs annually. As a manufacturer prepares to bring any new drug to market, there are several important decisions to...
